Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2026-05-27 @ 2:02 AM
Study NCT ID:
NCT05565092
Status:
TERMINATED
Last Update Posted:
2025-01-13
First Post:
2022-09-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALXN1820-SCD-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None